Bernhard Lieb

Title: Bernhard Lieb: Innovator in Nucleic Acid Technology

Introduction

Bernhard Lieb is a notable inventor based in Mainz, Germany. He has made significant contributions to the field of biotechnology, particularly in the development of nucleic acid molecules. With a total of 3 patents, his work has implications for both medical and pharmaceutical applications.

Latest Patents

Lieb's latest patents focus on nucleic acid molecules that code for haemocyanins. One of his inventions describes a nucleic acid molecule or construct that includes a promoter suitable for expression control. This construct codes for a KLH1 haemocyanin, a haemocyanin domain, or a fragment with immunological properties. It also comprises at least one intron sequence and haemocyanin fusion proteins. Furthermore, the construct can include a nucleic acid sequence coding for an antigen. Host cells containing this nucleic acid molecule or construct are also contemplated, along with a recombinant expression product. The invention extends to a pharmaceutical composition that includes the expression product and antibodies obtained through animal immunization, which can be used in screening methods for tumor identification.

Career Highlights

Throughout his career, Bernhard Lieb has worked with various companies, including Biosyn Arzneimittel GmbH. His innovative work has positioned him as a key figure in the biotechnology sector, contributing to advancements in medical research and treatment options.

Collaborations

Lieb has collaborated with notable professionals in his field, including Jürgen Markl and Benjamin Altenhein. These collaborations have further enriched his research and development efforts.

Conclusion

Bernhard Lieb's contributions to nucleic acid technology and his innovative patents highlight his role as a significant inventor in the biotechnology field. His work continues to influence medical research and pharmaceutical development.